Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 11, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Insight into human allogeneic CAR-T therapy: an open-access dataset.

Natalia Obajtek1, Bartek Lisowski1, Seweryn Ulaszek2

  • 1Chair of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.

Drug Discovery Today
|June 9, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hysteretic Conductance in Ion Channel Gating.

Entropy (Basel, Switzerland)·2026
Same author

CAR-Tography of modeling approaches and opportunities in cellular therapy of cancer.

Folia medica Cracoviensia·2026
Same author

Targeting Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma: Rationale, Current Evidence, and a CEACAM6 CAR-T Strategy.

Cancers·2026
Same author

Development and Implementation of a Hinderance-based In Vitro Model for Porous Membranes.

The AAPS journal·2026
Same author

In Vitro Analysis and Dynamic Modeling of SARS-CoV-2 Infection Inhibition by Sigma-1 Receptor Antagonist PB28.

Bulletin of mathematical biology·2026
Same author

Relating plaque psoriasis barrier function changes with the underlying skin morphology and physiology.

Journal of pharmaceutical sciences·2026

Allogeneic CAR-T cell therapy shows promise for blood cancers. This study compiles clinical trial data to improve mathematical models for allogeneic CAR-T cell therapy, enhancing understanding of its effectiveness.

Area of Science:

  • Immunotherapy
  • Oncology
  • Pharmacometrics

Background:

  • Chimeric antigen receptor T-cell (CAR-T) therapy is effective for various cancers, often used after other treatments.
  • Allogeneic CAR-T products offer advantages over autologous options, including better cell quality and cost-effectiveness.
  • Mathematical modeling is crucial for understanding CAR-T cell exposure-response relationships due to their unique nature.

Purpose of the Study:

  • To address the challenge of limited and fragmented clinical data for CAR-T cell therapy.
  • To create a comprehensive dataset of human clinical trials involving allogeneic CAR-T cells for hematological disorders.
  • To facilitate robust parametrization of mathematical models for allogeneic CAR-T cell therapy.

Main Methods:

  • Aggregation of human clinical trial data.
Keywords:
CAR-T therapyCAR‑T cell kineticsallogeneic CAR-Tdatabase

More Related Videos

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Related Experiment Videos

Last Updated: Jun 11, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

  • Focus on trials utilizing allogeneic CAR-T cells.
  • Data compilation for hematological disorders.

    • Main Results:

    • A comprehensive dataset of allogeneic CAR-T cell clinical trials has been established.
    • The dataset facilitates improved data availability and quality for modeling purposes.
    • This resource supports the development of more accurate exposure-response models.

    Conclusions:

    • The curated dataset is essential for advancing the mathematical modeling of allogeneic CAR-T cell therapy.
    • Improved models can lead to a better understanding of CAR-T cell efficacy and safety.
    • This work supports the optimization of allogeneic CAR-T cell treatments for hematological malignancies.